Close

Form EFFECT ADIAL PHARMACEUTICALS,

June 30, 2022 6:06 AM EDT

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: June 29, 2022
Accession Number: 0001213900-22-034938
Submission Type: POS AM
CIK: 0001513525
Company Name: ADIAL PHARMACEUTICALS, INC.
File Number: 333-220368


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings